Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision therapy for lymphoma--current state and future directions.

Nature reviews. Clinical oncology - 1 Oct 2014

Intlekofer Andrew M, Younes Anas

Abstract excerpt

Modern advances in genomics and cancer biology have produced an unprecedented body of knowledge regarding the molecular pathogenesis of lymphoma. The diverse histological subtypes of lymphoma are molecularly heterogeneous, and most likely arise from distinct oncogenic mechanisms. In parallel to these advances in lymphoma biology, several new classes of molecularly targeted agents have been developed with varying...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Genetic Heterogeneity
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma

Share to Lymphoma Diagnosis and Treatment

Share to Molecular Targeted Therapy

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 25135367
DOI: 10.1038/nrclinonc.2014.137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision therapy for lymphoma--current state and future directions.PMID 25135367Read ↗

New Insights into Lymphoma PathogenesisSemantic proximity Read ↗

Towards precision medicine in lymphoid malignanciesSemantic proximity Read ↗

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsSemantic proximity Read ↗

Harnessing tumor-agnostic biomarkers for precision medicine in lymphoma.Semantic proximity Read ↗

Precision diagnostics in lymphomas - Recent developments and future directions.Semantic proximity Read ↗

Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine.Semantic proximity Read ↗

Precision Treatment of Distinct Molecular Subtypes of Diffuse Large B-cell Lymphoma: Ascribing Treatment Based on the Molecular PhenotypeSemantic proximity Read ↗

Single‑cell multi‑omics advances in lymphoma research (Review)Semantic proximity Read ↗

Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma.Semantic proximity Read ↗

Diagnostic and prognostic molecular pathology of lymphoid malignancies.Semantic proximity Read ↗

New targeted therapies for malignant lymphoma based on molecular heterogeneity.Semantic proximity Read ↗

A genetic profiling guideline to support diagnosis and clinical management of lymphomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.